Moody National Bank Trust Division Sells 21,583 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Moody National Bank Trust Division lessened its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 45.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 26,410 shares of the company’s stock after selling 21,583 shares during the period. Moody National Bank Trust Division’s holdings in Pediatrix Medical Group were worth $346,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in MD. Quest Partners LLC raised its position in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares during the period. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares in the last quarter. CWM LLC raised its holdings in Pediatrix Medical Group by 134.0% in the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock worth $74,000 after purchasing an additional 3,681 shares during the period. Canada Pension Plan Investment Board purchased a new position in Pediatrix Medical Group during the second quarter valued at $72,000. Finally, FMR LLC grew its holdings in Pediatrix Medical Group by 220.6% during the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after purchasing an additional 6,771 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $13.63 on Wednesday. The company has a market cap of $1.17 billion, a P/E ratio of -4.45, a P/E/G ratio of 2.00 and a beta of 1.58. The firm’s fifty day moving average is $14.26 and its two-hundred day moving average is $11.67. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $16.41.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The company had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same period in the prior year, the company earned $0.29 earnings per share. The firm’s revenue was up .9% on a year-over-year basis. As a group, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on MD. Mizuho raised their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 19th. UBS Group raised their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 9th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group upped their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $16.25.

Insider Activity at Pediatrix Medical Group

In related news, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now owns 135,810 shares in the company, valued at approximately $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Mark S. Ordan sold 27,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the sale, the director now directly owns 138,683 shares in the company, valued at $2,128,784.05. The trade was a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.